Objective: To analyze the influencing factors on AIDS-related deaths among HIV/AIDS patients in Guangzhou, Guangdong province.
Methods: A retrospective cohort was formed, based on available data of HIV/AIDS patients between 1991 and 2013 in Guangzhou, that were gathered from the Chinese AIDS Prevention and Control Information System. Cox proportional hazard model was used to identify the influencing factors for AIDS-related deaths.
Results: Data showed that factors as: existence of full-bloom AIDS when HIV infection was diagnosed (HR =2.717, 95%CI: 2.039-3.621) , diagnose of AIDS was made in the hospitals (HR=1.516, 95%CI: 1.159-1.981) , never received no CD(4) count testing (HR=4.866, 95%CI: 3.674-6.444) , no drugs were provided to those who met the criteria for treatment (HR=12.213, 95%CI: 8.467-17.616) , and patients at aged ≥40 years when HIV infection was diagnosed etc., were related to the risk for AIDS deaths. The risk of AIDS-related death was also high in those who did not meet the treatment criteria or receiving no treatment, when compared to those who had received the antiviral treatment (HR=1.936, 95%CI: 1.145-3.272).
Conclusion: Factors as: earlier diagnosis of HIV/AIDS cases, provision of CD(4) count testing and antiviral treatment to more cases etc, could decrease the risk for AIDS-related deaths and improve the survival rate on HIV/AIDS cases.
Download full-text PDF |
Source |
---|
HIV Med
January 2025
National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain.
Objectives: We aimed to describe health-related quality of life (HRQoL), overall and across its dimensions, identify associated factors, and assess changes over time among people with HIV (PWH) from the Spanish multicentre CoRIS cohort.
Methods: We developed a mobile app to collect HRQoL data every 3 months using the WHOQOL-HIV-BREF questionnaire (31 items across six domains), among PWH followed in CoRIS in 2021-2023. Factors associated with good/very good global HRQoL and with domain-specific mean scores were identified using multivariable logistic and linear regression, respectively.
BMC Infect Dis
January 2025
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA.
Introduction: The incidence rate of newly diagnosed HIV infection in Indonesia decreased from 21 per 100,000 in 2011 to 10 per 100,000 in 2021. Despite this progress, AIDS-related deaths among people living with HIV (PLWH) increased from 3.4% in 2010 to 4.
View Article and Find Full Text PDFBMJ Open
January 2025
Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, United Republic of Tanzania.
Objectives: This study aims to assess the magnitude of opportunistic infection (OI) and to identify factors associated with OIs among people living with HIV (PLHIV) on antiretroviral treatment (ART), attending HIV care and treatment clinics.
Design: A hospital-based cross-sectional study.
Setting: The study was conducted at Muhimbili National Hospital, Mwananyamala and Temeke Regional Referral Hospitals, in Dar es Salaam, Tanzania.
South Afr J HIV Med
December 2024
Department of Anatomical Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Background: Liver disease is the leading cause of non-AIDS-related mortality in people living with HIV (PLWH). Steatotic liver disease (SLD) is increasingly recognised as an important aetiological factor in liver dysfunction in PLWH.
Objectives: This study aimed to determine the post-mortem prevalence and severity of SLD and determine HIV- and non-HIV-related risk factors associated with it.
Aging Cell
January 2025
Department of Internal Medicine and Radboud Center of Infectious Diseases, Radboudumc, Radboud University, Nijmegen, The Netherlands.
Due to the increased burden of non-AIDS-related comorbidities in people living with HIV (PLHIV), identifying biomarkers and mechanisms underlying premature aging and the risk of developing age-related comorbidities is a priority. Evidence suggests that the plasma proteome is an accurate source for measuring biological age and predicting age-related clinical outcomes. To investigate whether PLHIV on antiretroviral therapy (ART) exhibit a premature aging phenotype, we profiled the plasma proteome of two independent cohorts of virally suppressed PLHIV (200HIV and 2000HIV) and one cohort of people without HIV (200FG) using O-link technology.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!